NEWS REVIEW – INDIA
[This article was published in the February 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
NEWS REVIEW
Tags: All India Institute of Ayurveda, Apollo Group Inc., Apollo Hospital, bangalore, Business Partnership, calibrator, california, Central Drugs Authority of India, Central Government, Commerce Minister, Company Expansion, delhi, Department of AYUSH, Department of Fundamental Research, drug development, Escorts Hospital, european union, Fortis hospital, Global Harmonization Task Force, Government of India, Haryana, health, Health/Medical/Pharmaceuticals, healthcare, Healthcare Access, healthcare facilities, Healthcare in India, healthcare reforms, Healthcare sector, hiranandani hospital, Holy Family Hospital, hospital, hospital chain, Hyderabad, India, Indonesia, Indraprastha Apollo Hospital, INR, insurance, Jharkhand, Karnataka, Kerala, Khubchandani Hospital, Koncentric Investments Limited, L H Hiranandani Hospital, Malaysia, Manmohan Singh, Maryland, Max Healthcare, Medical Devices Regulatory Authority of India, medical tourism, Medical Trust Hospital, Medicare, medicine, Ministry of Health and Family Welfare, MRI, mumbai, NASSCOM, Nasscom-ICICI Knowledge Park Innovation Fund, NEWS REVIEW, NHS, Person Travel, PET CT Scan centre, player, Prakash Khubchandani, pre-eminent healthcare groups, President, preventive healthcare, Prime Minister, private healthcare, Research and Referral Hospital, Santa Clara, secondary and tertiary healthcare, Singapore, surgery, Tarana Khubchandani, United Kingdom, United States, USD, Vice President, West Bengal
NEWS REVIEW – WORLD
[This article was published in the February 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
NEWS REVIEW
Yos Technologies launches comprehensive healthcare system
Yos Technologies, the newest entrant in the healthcare IT domain, based in Bangalore has announced the general availability of its flagship product YosCare.
ICICI Venture buys majority stake Vikram (Mysore)
ICICI Venture, part of the financial conglomerate, the ICICI Group, has announced that it has taken a majority stake in the Mysore-based healthcare company, Vikram Hospital Private Ltd (VHPL).
Next-gen RFID solutions are battery-based
A partnership between GE Healthcare and CenTrak, Inc., a tracking solutions provider based in Newtown, Pa., has led to the development of a predominantly battery-operated radio frequency ID tracking system.
Axon Lab, iSoft
iSoft has announced its re-entry into the Swiss market through a distribution agreement, just 18-months after it sold its Swiss operations.
GE Healthcare launches indigenous, next-gen X-ray system
GE Healthcare, the US$17 billion healthcare business of General Electric Company recently announced the launch of “Tejas XR 6000”, a next generation convertible X ray system in India.
British NHS patients soon to be treated in India
In a ground breaking move, the British government is to allow patients with non-emergency conditions to be treated in Indian hospitals under a scheme paid for by British taxpayers.
PREMIUM PRODUCTS – Health Insurance : Ivan Chak, Head, Life Profit Centre and Accident & Health division, Tata AIG Life Insurance Company Ltd.
In the short term perspective health insurance industry is expected to grow at a rate of 25% annually till 2010, while in the long term, it is expected to grow at a rate of 5% annually thereafter.
GE Healthcare creates vendor-independent healthcare IT educational program
GE Healthcare, a leading provider of healthcare information technology solutions, announced a vendor-independent educational program, designed specifically for biomedical and technical professionals, to enhance their knowledge of IT concepts for healthcare.
China unveils healthcare scheme
China’s Health Minister has announced an ambitious program to provide basic healthcare for every citizen in the world’s most populous nation.
India’s Drug Regulatory Authority to be based on US FDA Model
In the next three years, India would move towards setting up a drug regulatory authority on the model of the US FDA, the country
